Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data.

Mahsa GhodousiHedyieh KarbasforooshanLeila Arabi Sepideh Elyasi

Published in: European journal of clinical pharmacology (2022)

Further studies are required to determine the optimal dose, duration, and the best formulation of silymarin to prevent and/or manage chemotherapy and radiotherapy-induced complications.

Keyphrases

locally advanced
high glucose
early stage
diabetic rats
radiation therapy
rectal cancer
squamous cell carcinoma
drug delivery
radiation induced
emergency department
endothelial cells
big data
machine learning
stress induced